Novartis’ Tekturna Is First Renin Inhibitor Approved For Hypertension

The first-in-class drug will launch later in March.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet